Skip to main content
Premium Trial:

Request an Annual Quote

Astex Technology Joins Protein Structure Software Consortium

NEW YORK, June 11 - British structural proteomics company Astex Technology has joined the Global Phasing consortium, giving Astex early access to Global Phasing's software for modeling protein structure using x-ray crystallography, the companies said Monday.

Astex, based in Cambridge, UK, joins several undisclosed pharmaceutical companies in the consortium. In addition to early access to software, membership in the consortium allows Astex scientists to consult with Global Phasing software developers. 

"Joining the Global Phasing consortium will significantly enhance Astex's ability to convert raw data from our X-ray crystallography machines into three dimensional structures of proteins, thus further improving our rational drug design capabilities," Harren Jhoti, Astex's chief scientific officer, said in a statement.

Global Phasing, also of Cambridge, UK, was founded by Gerard Bricogne, a protein structure researcher at the Medical Research Council's Laboratory of Molecular Biology in Cambridge. The company develops software for converting x-ray crystallography experimental data into 3-dimensional protein structures.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.